Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 290

Symbio secures $30m

Symbio Robotics has received cash from the UC Berkeley-linked House Fund as it announces its official company launch.

Feb 25, 2021

Aviatrix navigates to $75m series D

Liberty Global Ventures has reinvested in the multicloud software-as-a-service platform in a deal that lifted Aviatrix's total funding to $151m.

Feb 25, 2021

PerimeterX picks up $57m of growth capital

Deutsche Telekom and other investors have helped the cybersecurity software developer achieve $144m of total funding.

Feb 25, 2021

ScienceLogic scoops up $105m in series E

Existing investor Intel Capital helped the IT monitoring software developer fill out its latest funding round, taking its total funding to $189m.

Feb 25, 2021

Teligene selects investors for $93m round

The Suzhong Pharma and China Construction Bank-backed cancer drug developer is gearing up for an initial public offering after securing a new capital injection.

Feb 25, 2021

Foxtrot Market stores $42m in series B

UChicago has once again backed the corner store operator, and the round was co-led by Almanac Insights and Monogram Capital Partners.

Feb 25, 2021

Katana Graph maps out series A details

The graph analytics technology startup has completed a $28.5m round that was led by Intel Capital and backed by Dell Technologies Capital.

Feb 25, 2021

Tarabut Gateway opens doors to $13m

Almoayed Technologies was among the investors in a seed round for the open banking API developer that was led by Target Global.

Feb 24, 2021

Evisort signs off on $35m series B

The contract management platform developer took its total funding to more than $55m in a round that included existing backer Microsoft.

Feb 24, 2021

Evisort signs off on $35m series B

The MIT and Harvard-linked contract management platform developer has taken its total funding to more than $55m.

Feb 24, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here